| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000011072 |
| Receipt No. | R000012954 |
| Official scientific title of the study | Histamine-2 Receptor Antagonist Versus Proton-Pump Inhibitor for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk (ASP (PPI_H2RA) Study) |
| Date of disclosure of the study information | 2013/06/29 |
| Last modified on | 2017/05/11 (Ver. 7) |
| Basic information | |||
| Official scientific title of the study |
Histamine-2 Receptor Antagonist Versus Proton-Pump Inhibitor for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk (ASP (PPI_H2RA) Study) |
||
| Title of the study (Brief title) |
H2RA VS PPI for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk |
||
| Region |
|
||
| Condition | ||||||
| Condition | Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk | |||||
| Classification by specialty |
|
|||||
| Classification by malignancy | Others | |||||
| Genomic information | NO | |||||
| Objectives | |
| Narrative objectives1 | to test the hypothesis that PPI is superior to H2RA for the prevention of recurrent ulcer bleeding in ASA users with a history ulcer bleeding. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Reccurent ulcer bleeding |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Double blind -all involved are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | famotidine 40 mg/day | |
| Interventions/Control_2 | rabeprazole 20 mg/day | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. A history of documented peptic ulcer bleeding (self-reported history without confirmation by the clinician is not acceptable)
2. Negative tests for H. pylori or successful eradication of H. pylori based on urease test and histology 3. Expected regular use of ASA for the duration of the trial 4. Age ≥ 18 5. Written informed consent obtained |
|||
| Key exclusion criteria | 1. A history of gastric or duodenal surgery other than patch repair
2. Severe erosive esophagitis (LA grade C or D) 3. Gastric outlet obstruction 4. Terminal illness 5. Active malignancies |
|||
| Target sample size | 332 | |||
| Research contact person | |
| Name of lead principal investigator | Francis KL Chan |
| Organization | Chinese University of Hong Kong |
| Division name | Faculty of Medicine |
| Address | Prince of Wales Hospital, Shatin, N.T., Hong Kong |
| TEL | 0666453811 |
| Public contact | |
| Name of contact person | Tetsuya Tanigawa |
| Organization | Osaka City University Graduate School of Medicine |
| Division name | Department of Gastroenterology |
| Address | |
| TEL | |
| Homepage URL | |
| ttanigawa@med.osaka-cu.ac.jp | |
| Sponsor | |
| Institute | Department of Gastroenterology
Osaka City University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | NCT01408186 |
| Org. issuing International ID_1 | ClinicalTrials.gov |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪市立大学 消化器内科
香港大学 消化器内科 佐賀大学 内科学 大阪医科大学 第二内科 島根大学 第二内科 木下芳一 大阪市立総合医療センター 消化器内科 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012954 |